Houghton Mifflin Harcourt Company [NASDAQ: HMHC] slipped around -0.27 points on Wednesday, while shares priced at $2.57 at the close of the session, down -9.51%. The company report on October 22, 2020 that Houghton Mifflin Harcourt Schedules Conference Call to Discuss Third Quarter 2020 Results.
Houghton Mifflin Harcourt (HMH) (NASDAQ: HMHC) today announced that it will release its third quarter 2020 financial and operating results on Thursday, November 5, 2020, before the market opens.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
At 9:30 a.m. ET on Thursday, November 5, 2020, HMH will also host a conference call to discuss the results with investors and analysts. The call will be webcast live at ir.hmhco.com. The following information is provided for investors who would like to participate:.
Houghton Mifflin Harcourt Company stock is now -58.88% down from its year-to-date (YTD) trading value. HMHC Stock saw the intraday high of $2.76 and lowest of $2.52 per share. The company’s 52-week high price is 6.85, which means current price is +149.51% above from all time high which was touched on 02/20/20.
Compared to the average trading volume of 3.91M shares, HMHC reached a trading volume of 1580811 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Houghton Mifflin Harcourt Company [HMHC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HMHC shares is $3.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HMHC stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Houghton Mifflin Harcourt Company shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 05, 2020. While these analysts kept the previous recommendation, BMO Capital Markets dropped their target price from $7 to $3. The new note on the price target was released on April 07, 2020, representing the official price target for Houghton Mifflin Harcourt Company stock. Previously, the target price had yet another drop from $7.50 to $1, while Citigroup kept a Sell rating on HMHC stock.
The Average True Range (ATR) for Houghton Mifflin Harcourt Company is set at 0.23, with the Price to Sales ratio for HMHC stock in the period of the last 12 months amounting to 0.26. The Price to Book ratio for the last quarter was 1.70. Price to Free Cash Flow for HMHC in the course of the last twelve months was 1.12 with Quick ratio for the last quarter at 0.70.
How has HMHC stock performed recently?
Houghton Mifflin Harcourt Company [HMHC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.07. With this latest performance, HMHC shares gained by 52.98% in over the last four-week period, additionally plugging by 60.62% over the last 6 months – not to mention a drop of -60.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HMHC stock in for the last two-week period is set at 48.40, with the RSI for the last a single of trading hit 42.83, and the three-weeks RSI is set at 50.74 for Houghton Mifflin Harcourt Company [HMHC]. The present Moving Average for the last 50 days of trading for this stock 2.34, while it was recorded at 2.87 for the last single week of trading, and 2.80 for the last 200 days.
Houghton Mifflin Harcourt Company [HMHC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Houghton Mifflin Harcourt Company [HMHC] shares currently have an operating margin of -10.33 and a Gross Margin at +37.48. Houghton Mifflin Harcourt Company’s Net Margin is presently recorded at -15.38.
Return on Total Capital for HMHC is now -9.91, given the latest momentum, and Return on Invested Capital for the company is -14.93. Return on Equity for this stock declined to -32.04, with Return on Assets sitting at -8.54. When it comes to the capital structure of this company, Houghton Mifflin Harcourt Company [HMHC] has a Total Debt to Total Equity ratio set at 141.41. Additionally, HMHC Total Debt to Total Capital is recorded at 58.58, with Total Debt to Total Assets ending up at 31.87. Long-Term Debt to Equity for the company is recorded at 136.52, with the Long-Term Debt to Total Capital now at 56.55.
Reflecting on the efficiency of the workforce at the company, Houghton Mifflin Harcourt Company [HMHC] managed to generate an average of -$62,892 per employee. Receivables Turnover for the company is 7.17 with a Total Asset Turnover recorded at a value of 0.56.Houghton Mifflin Harcourt Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.10.
Earnings analysis for Houghton Mifflin Harcourt Company [HMHC]
With the latest financial reports released by the company, Houghton Mifflin Harcourt Company posted 0.55/share EPS, while the average EPS was predicted by analysts to be reported at 0.61/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -9.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HMHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Houghton Mifflin Harcourt Company go to 5.00%.
Insider trade positions for Houghton Mifflin Harcourt Company [HMHC]
There are presently around $301 million, or 94.00% of HMHC stock, in the hands of institutional investors. The top three institutional holders of HMHC stocks are: ANCHORAGE CAPITAL GROUP, L.L.C. with ownership of 19,465,570, which is approximately 0% of the company’s market cap and around 0.50% of the total institutional ownership; WELLINGTON MANAGEMENT GROUP LLP, holding 15,368,957 shares of the stock with an approximate value of $39.5 million in HMHC stocks shares; and ALLIANCEBERNSTEIN L.P., currently with $20.35 million in HMHC stock with ownership of nearly -6.431% of the company’s market capitalization.
Positions in Houghton Mifflin Harcourt Company stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 52 institutional holders increased their position in Houghton Mifflin Harcourt Company [NASDAQ:HMHC] by around 11,515,098 shares. Additionally, 63 investors decreased positions by around 15,662,072 shares, while 12 investors held positions by with 89,807,854 shares. The mentioned changes placed institutional holdings at 116,985,024 shares, according to the latest SEC report filing. HMHC stock had 13 new institutional investments in for a total of 2,503,880 shares, while 22 institutional investors sold positions of 4,322,883 shares during the same period.